NCT01363323View on ClinicalTrials.gov

Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

PHASE1CompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

February 28, 2005

Conditions
Healthy Volunteers
Interventions
DRUG

Methylnaltrexone (MNTX)

Dose 1

DRUG

Methylnaltrexone (MNTX)

Dose 2

DRUG

Methylnaltrexone (MNTX)

Dose 3

DRUG

Placebo

DRUG

Moxifloxacin

Trial Locations (1)

10591

Progenics Pharmaceuticals, Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01363323 - Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization | Biotech Hunter | Biotech Hunter